Target Price | $7.67 |
Price | $1.79 |
Potential |
328.31%
register free of charge
|
Number of Estimates | 6 |
6 Analysts have issued a price target Nuvation Bio Inc - Ordinary Shares - Class A 2026 .
The average Nuvation Bio Inc - Ordinary Shares - Class A target price is $7.67.
This is
328.31%
register free of charge
$10.00
458.66%
register free of charge
$5.00
179.33%
register free of charge
|
|
A rating was issued by 7 analysts: 7 Analysts recommend Nuvation Bio Inc - Ordinary Shares - Class A to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Nuvation Bio Inc - Ordinary Shares - Class A stock has an average upside potential 2026 of
328.31%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 7.87 | 33.49 |
325.60% | ||
Net Margin | -9,057.72% | -669.41% |
92.61% |
7 Analysts have issued a sales forecast Nuvation Bio Inc - Ordinary Shares - Class A 2025 . The average Nuvation Bio Inc - Ordinary Shares - Class A sales estimate is
This results in the following potential growth metrics:
4 Nuvation Bio Inc - Ordinary Shares - Class A Analysts have issued a net profit forecast 2025. The average Nuvation Bio Inc - Ordinary Shares - Class A net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.11 | -0.66 |
502.86% | 68.72% | |
P/E | negative | |
EV/Sales | 3.36 |
4 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast for earnings per share. The average Nuvation Bio Inc - Ordinary Shares - Class A EPS is
This results in the following potential growth metrics and future valuations:
Nuvation Bio Inc - Ordinary Shares - Class A...
Analyst | Rating | Action | Date |
---|---|---|---|
Jones Trading |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 10 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 23 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 22 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Jan 07 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 06 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Nov 07 2024 |
Analyst Rating | Date |
---|---|
Locked
Jones Trading:
Locked
➜
Locked
|
Mar 12 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 10 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 23 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 22 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Jan 07 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 06 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Nov 07 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.